Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
After the shortage ended, 503B bulk compounding of tirzepatide is effectively blocked, and the FDA proposed in April 2026 to keep it off the 503B bulks list
Feeling utterly drained
The high cost of tirzepatide and similar medications is primarily due to the expensive research and development processes required
He subsequently received diuretics to treat his acute exacerbation of heart failure with preserved ejection fraction along with medically-supervised fasting to qualify for and proceed to elective, life-saving bariatric surgery
Sources and Further Reading Seiwerth et al
US$ 20.01
US$ 21.95
US$ 23.12
US$ 24.14
